Evidence map›Paper›PMID 32956786›Full record

ReviewThe Journal of hospital infection2020

Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2.

G Kampf, Y Brüggemann, H E J Kaba, J Steinmann, S Pfaender, S Scheithauer, E Steinmann

Abstract readComparative StudyReview
In one paragraph

Review in The Journal of hospital infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Accurate Estimation of Individual Transmission Rates Through Contact Analytics Using UWB Based Indoor Location Data.International Conference on Smart Applications, Communications and Networking : SmartNets. International Conference on Smart Applications, Communications and Networking · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Antimicrobial FeScientific reports · 2023
    Article
  14. Risk assessment of banknotes as a fomite of SARS-CoV-2 in cash payment transactions.Risk analysis : an official publication of the Society for Risk Analysis · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

G KampfUniversity Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.
Y BrüggemannDepartment of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
H E J KabaInstitute of Infection Control and Infectious Diseases, University Medical Center, Georg August University, Göttingen, Germany.
J SteinmannInstitute of Clinical Hygiene, Medical Microbiology and Infectiology, General Hospital Nürnberg, Paracelsus Medical University, Nürnberg, Germany.
S PfaenderDepartment of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
S ScheithauerInstitute of Infection Control and Infectious Diseases, University Medical Center, Georg August University, Göttingen, Germany.
E SteinmannDepartment of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the current SARS-CoV-2 pandemic new studies are emerging daily providing novel information about sources, transmission risks and possible prevention measures. In this review, we aimed to comprehensively summarize the current evidence on possible sources for SARS-CoV-2, including evaluation of transmission risks and effectiveness of applied prevention measures. Next to symptomatic patients, asymptomatic or pre-symptomatic carriers are a possible source with respiratory secretions as the most likely cause for viral transmission. Air and inanimate surfaces may be sources; however, viral RNA has been inconsistently detected. Similarly, even though SARS-CoV-2 RNA has been detected on or in personal protective equipment (PPE), blood, urine, eyes, the gastrointestinal tract and pets, these sources are currently thought to play a negligible role for transmission. Finally, various prevention measures such as handwashing, hand disinfection, face masks, gloves, surface disinfection or physical distancing for the healthcare setting and in public are analysed for their expected protective effect.

Indexed as

Carrier StateCOVID-19Disease Transmission, InfectiousGloves, ProtectiveHand DisinfectionHealth FacilitiesHumansMasksPandemicsPersonal Protective EquipmentSARS-CoV-2epidemiologypreventionSARS-CoV-2sourcestransmission

Identifiers

PMID32956786
PMCPMC7500278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.